## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -3.2% below STRENGTH zone (4.0-10.0%); PEG 3.57 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($532.94)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Pilotless fighter jets could transform aerial warfare**
- Source: Fox Business | 20251208T203505 | Bullish | Relevance: 99%
-  Northrop Grumman has unveiled "Project Talon," an autonomous combat drone designed to serve as a "loyal wingman" to piloted fighter aircraft. This pilotless jet offers significant cost savings compared to traditional fighter jets, with a projected price range of $15 million to $20 million, and can perform various combat tasks. The ethical consideration of human involvement in weapon firing decisions remains a key aspect for this new technology, which is currently garnering interest from U.S. and international armed forces.

**2. Northrop Grumman unveils 'Project Talon' autonomous aircraft**
- Source: Fox Business | 20251209T161227 | Bullish | Relevance: 98%
-  Northrop Grumman Aeronautics Sector President Tom Jones discussed the company's "Project Talon" autonomous jet. This video clip provides details on the new autonomous aircraft from Northrop Grumman.

**3. New 4-Star Stocks**
- Source: Morningstar | 20251208T150802 | Somewhat-Bullish | Relevance: 78%
-  This article identifies seven US-listed stocks that recently became undervalued, earning a 4-star Morningstar Rating. The top five, based on market capitalization, are CVS Health, Marvell Technology, Northrop Grumman, Datadog, and Diamondback Energy. The Morningstar Rating system helps investors spot undervalued stocks by comparing market price to fair value estimate and considering uncertainty.

**4. U.S. Approves $3.73B Missile, Air Defense Sale to Denmark**
- Source: Defense Mirror | 20251206T075900 | Somewhat-Bullish | Relevance: 72%
-  The U.S. State Department has approved a $3.73 billion Foreign Military Sale to Denmark, encompassing air-to-air missiles and an integrated ground-based air defense system. The sale includes 200 AIM-120C-8 air-to-air missiles valued at $730 million, with RTX Corporation as the principal contractor. Additionally, a $3 billion package for an Integrated Battle Command System with Indirect Fire Protection Capability features various radars, launchers, and command centers, with RTX Corporation, Lockheed Martin, Leidos, and Northrop Grumman as leading contractors.

**5. Boeing exec: Trump's government stake plan doesn't apply to defense primes**
- Source: Seeking Alpha | 20251208T033900 | Neutral | Relevance: 71%
- A Boeing official stated that former President Donald Trump's plan for government equity stakes in strategic industries does not apply to major defense firms like Boeing. The report indicates the government's desire for companies to invest more in facilities, particularly larger ones.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.08M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Near-term weakness: 5.3% below SMA50 despite long-term uptrend.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.57 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $79.3B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.57 |
| Forward P/E | 19.2 |
| Current P/E | 21.3 |
| YoY Growth | 10.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.7% to -3.2% (+1.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 7.2pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.2%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). RSI neutral at 40.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.22% (CS: 29) | Weak |
| RSI_14 | 40.4 | Neutral |
| MACD Histogram | -0.19 | Bearish |
| vs SMA20 | 0.988x | Below |
| vs SMA50 | 0.947x | Below |
| vs SMA200 | 1.031x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $553.56
- **Stop Loss:** $532.94 (3.7% risk)
- **Target:** $574.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 24
- **Position Value:** $13,285.44
- **Portfolio %:** 13.29%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*